Tolmar International Limited
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Apr 3 to 10, 2027 · next Apr 3
- 1 fee due Sep 19, 2027The maintenance fee for Systems and Methods for Mixing Syringe Valve Assemblies (US 11,931,559) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 23, 2026
- Oct 13 US 12,758,609 Leuprolide Acetate Compositions and Methods of Using the Same to Treat Breast Cancer
- Oct 13 US 12,758,491 Polymeric Leuprolide Acetate Formulations
- Oct 6 US 12,751,990 Method of Treating a Child with Central Precocious Puberty using an Extended Release Composition
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,786,515 | Liquid Polymer Delivery System for Extended Administration of Drugs In force · High confidence | In force | High confidence | |
| US 11,779,589 | Liquid Polymer Delivery System for Extended Administration of Drugs In force · High confidence | In force | High confidence | |
| US 12,447,158 | Liquid Polymer Delivery System for Extended Administration of Drugs In force · High confidence | In force | High confidence | |
| US D1,029,245 | Syringe Connector In force · High confidence | In force | High confidence | |
| US 12,751,990 | Method of Treating a Child with Central Precocious Puberty using an Extended Release Composition In force · High confidence | In force | High confidence | |
| US 12,758,609 | Leuprolide Acetate Compositions and Methods of Using the Same to Treat Breast Cancer In force · High confidence | In force | High confidence | |
| US 11,771,841 | Systems and Methods for Mixing Syringe Valve Assemblies In force · High confidence | In force | High confidence | |
| US 11,931,559 | Systems and Methods for Mixing Syringe Valve Assemblies In force · High confidence | In force | High confidence | |
| US 12,397,120 | Systems and Methods for Mixing Syringe Valve Assemblies In force · Low confidence | In force | Low confidence | |
| US 12,453,754 | Leuprolide Acetate Compositions and Methods of Using the Same to Treat Breast Cancer In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 abandoned · 2 no status recorded